KO
38
-3
DE
42
3
AMT
37
3
IRM
41
3
PDCO
29
2
ZBH
65
3
COF
62
3
NI
72
4
HUM
41
-4
T
48
3
SEE
53
3
PG
50
2
IPG
34
-9
O
17
-13
LRCX
37
-9
ORCL
63
-4
WHR
65
-5
JNPR
50
-6
GILD
47
-8
SWK
50
-5
KO
38
-3
DE
42
3
AMT
37
3
IRM
41
3
PDCO
29
2
ZBH
65
3
COF
62
3
NI
72
4
HUM
41
-4
T
48
3
SEE
53
3
PG
50
2
IPG
34
-9
O
17
-13
LRCX
37
-9
ORCL
63
-4
WHR
65
-5
JNPR
50
-6
GILD
47
-8
SWK
50
-5
Financhill
Back

Matthews Emerging Markets Eq Actv ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
48

MEM
Matthews Emerging Markets Eq Actv ETF

Last Price:
31.81
Seasonality Move:
8.48%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
48
Matthews Emerging Markets Eq Actv ETF (MEM) is a Sell

Is Matthews Emerging Markets Eq Actv ETF a Buy, Sell or Hold?

  • The current Matthews Emerging Markets Eq Actv ETF [MEM] share price is $31.46. The Score for MEM is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • MEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MEM Stock Price Chart

What is Matthews Emerging Markets Eq Actv ETF's stock price today?

  • The Matthews Emerging Markets Eq Actv ETF share price today is $31.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEM is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 37.07 Sell
Chaikin Money Flow: 262 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.12 - 33.26) Sell
Bollinger Bands (100): (30.02 - 32.9) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

MEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.16 Sell
20-day SMA: 32.58 Sell
50-day SMA: 32.49 Sell
200-day SMA: 30.41 Buy
8-day EMA: 31.99 Sell
20-day EMA: 32.42 Sell
50-day EMA: 32.29 Sell
200-day EMA: 30.59 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Matthews Emerging Markets Eq Actv ETF Earnings Growth & MEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Matthews Emerging Markets Eq Actv ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):